AVDL
Avadel Pharmaceuticals
AVDL
AVDL
52 hedge funds and large institutions have $299M invested in Avadel Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% more funds holding
Funds holding: 35 → 52 (+17)
12% more call options, than puts
Call options by funds: $925K | Put options by funds: $825K
Holders
52
Holding in Top 10
4
Calls
$925K
Puts
$825K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$20.1M | |
| 3 | +$20.1M | |
| 4 |
Millennium Management
New York
|
+$14.5M |
| 5 |
CCM
Consonance Capital Management
New York
|
+$14M |
Top Sellers
| 1 | -$728K | |
| 2 | -$631K | |
| 3 | -$468K | |
| 4 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
-$241K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$116K |